Fiduciary Planning’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Fiduciary Planning's PFE Position: Q1 2026 in Review
Fiduciary Planning reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $28.4K and leaving 7,433 shares worth $209K. The position accounts for 0.06% of the portfolio, ranked #71.
Fiduciary Planning first reported a position in PFE in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.97M in Q1 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Fiduciary Planning held 7,433 shares of Pfizer worth $209K as of Q1 2026.
- Fiduciary Planning sold 1,065 Pfizer shares in Q1 2026, an estimated $28.4K.
- Pfizer made up 0.06% of Fiduciary Planning's portfolio in Q1 2026, its #71 holding.
- Fiduciary Planning first reported a position in Pfizer in Q4 2019 and has held it in 19 quarters since.
- Fiduciary Planning's Pfizer position peaked at $1.97M in Q1 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Fiduciary Planning's 13F filing for Q1 2026, filed 27 Apr 2026.